Pharmaceutical - Sanofi Pasteur

Filter

Current filters:

Sanofi Pasteur

Popular Filters

Japan marketing approval for Canaglu; vaccine license for Daiichi Sankyo

Japan marketing approval for Canaglu; vaccine license for Daiichi Sankyo

04-07-2014

Japanese drug major Mitsubishi Tanabe Pharma has received approval to manufacture and market the SGLT2…

canagliflozinCanagluDaiichi SankyoDiabetesJapanMitsubishi TanabePharmaceuticalRegulationSanofi PasteurVaccines

CureVac in deal with Sanofi Pasteur for mRNA-based prophylactic vaccine

01-07-2014

German clinical-stage biopharma company CureVac has entered into an exclusive license agreement with…

LicensingPharmaceuticalSanofiSanofi PasteurVaccines

Sanofi Pasteur inks deal with Korea’s SK Chemical on vaccines

Sanofi Pasteur inks deal with Korea’s SK Chemical on vaccines

19-03-2014

In a second collaboration in less than a month, Sanofi Pasteur, the vaccines division of French drug…

Asia-PacificLicensingPharmaceuticalResearchSanofiSanofi PasteurSK ChemicalVaccines

Sanofi Pasteur wins order for IPV from UNICEF, cutting price to $1 per dose

28-02-2014

Sanofi Pasteur, the vaccines division of French drug major Sanofi, says that UNICEF, the organization…

GlobalMarkets & MarketingPharmaceuticalPricingSanofiSanofi PasteurVaccines

US NIH trials flu vaccines from Sanofi and Novartis

US NIH trials flu vaccines from Sanofi and Novartis

19-09-2013

The US National Institutes of Health has begun testing an H7N9 avian influenza vaccine candidate in humans.

GlaxoSmithKlineHealthcareNorth AmericaNovartisPharmaceuticalSanofi PasteurVaccines

Sanofi says pediatric vaccine Hexyon/Hexacima approved in Europe

22-04-2013

The European Commission has approved French drug major Sanofi (Euronext: SAN) subsidiary Sanofi Pasteur's…

EuropeHexacimaHexyonMerck & CoPharmaceuticalRegulationSanofiSanofi PasteurSanofi Pasteur MSDVaccines

Sanofi Pasteur MSD files for EU approval of "Quadrivalent" flu vaccine

11-04-2013

Sanofi Pasteur MSD, the joint venture between French drug major Sanofi (Euronext: SAN) vaccines unit…

EuropeMerck & CoPharmaceuticalRegulationSanofiSanofi PasteurSanofi Pasteur MSDVaccines

CHMP recommends approval of Sanofi Pasteur's Hexyon/Hexacima 6-1 pediatric vaccine

22-02-2013

CHMP recommends approval of Sanofi Pasteur's Hexyon/Hexacima 6-1 pediatric vaccine

EuropeHexacimaHexyonPharmaceuticalRegulationSanofiSanofi PasteurVaccines

Sanofi eyes big plans for China

11-02-2013

French pharmaceutical giant Sanofi (Euronext: SAN) plans to complete building a large plant for the production…

Asia-PacificPharmaceuticalProductionSanofiSanofi PasteurVaccines

UK first major European country to run Zostavax shingles vaccination program

22-01-2013

The UK has decided to launch the first-ever national shingles immunization campaign in Europe using the…

EuropeHealthcareMerck & CoPharmaceuticalSanofiSanofi PasteurSanofi Pasteur MSDVaccinesZostavax

Australian launch for Sanofi Pasteur's Imojev, first single-dose vaccine against Japanese encephalitis

11-12-2012

Sanofi Pasteur, the vaccines division of Sanofi (Euronext: SAN) has launched its Imojev vaccine against…

Asia-PacificImojevMarkets & MarketingPharmaceuticalSanofiSanofi PasteurVaccines

CREW files motion to quash Sanofi Pasteur subpoena

06-12-2012

Washington DC, USA-based non-profit legal watchdog group Citizens for Responsibility and Ethics (CREW)…

LegalMarkets & MarketingNorth AmericaPharmaceuticalSanofiSanofi PasteurVaccines

Health Canada approves Vertex' Kalydeco; and Sanofi Pasteur's Menactra

03-12-2012

Vertex Pharmaceuticals (Nasdaq: VRTX) says that Health Canada has approved Kalydeco (ivacaftor), the…

BiotechnologyKalydecoMenactraNorth AmericaPharmaceuticalRare diseasesRegulationSanofiSanofi PasteurVaccinesVertex

US FDA agrees to review Sanofi Pasteur's new quadrivalent influenza vaccine

18-10-2012

Sanofi Pasteur, the vaccines division of Sanofi (Euronext: SAN) says it has filed a supplemental Biologics…

Anti-viralsNorth AmericaPharmaceuticalRegulationSanofiSanofi PasteurVaccines

Sanofi Pasteur's dengue vaccine proves effective and safe; FDA identifies cGMP deviations

25-07-2012

French drug major Sanofi (Euronext: SAN) vaccines subsidiary Sanofi Pasteur sais this morning that its…

PharmaceuticalRegulationResearchSanofiSanofi PasteurTropical diseasesVaccines

Sanofi Pasteur starts shipping Fluzone in USA for 2012-2013 flu season

17-07-2012

The first lots of Fluzone vaccine have began shipping to US health care providers following Food and…

Anti-viralsFluzoneMarkets & MarketingNorth AmericaPharmaceuticalSanofiSanofi PasteurVaccines

US consumer groups call on FTC to investigate anti-competitive practices of vaccine makers

21-03-2012

In the USA, Citizens for Responsibility and Ethics in Washington (CREW), the National Legislative Association…

CervarixGardasilMarkets & MarketingMerck & CoNorth AmericaPharmaceuticalPricingSanofiSanofi PasteurVaccines

Sanofi Pasteur and Vivalis extend MAb accord

19-01-2012

French biopharma company Vivalis (NYSE Euronext: VLS) says it has extended the agreement signed in 2010…

Antibiotics and Infectious diseasesLicensingPharmaceuticalResearchSanofiSanofi PasteurVivalis

Sanofi Pasteur enters $3 billion acne treatment market in deal with UC San Diego

22-09-2011

Moving into a new therapeutic sector, Sanofi Pasteur, the vaccines division of French drug major Sanofi…

LicensingPharmaceuticalResearchSanofiSanofi PasteurVaccines

Back to top